Click a link below to view the mailing archive as if it had been sent to you.
| 2024-08-30 12:15 | | Invisalign maker reaches $27.5 million settlement of consumer antitrust lawsuit and more... |
| 2024-08-30 00:15 | | Novartis and Genentech’s Xolair is rising rapidly on TV and more... |
| 2024-08-29 12:15 | | J&J submits touted autoimmune disease drug for FDA approval and more... |
| 2024-08-29 00:15 | | Eli Lilly’s lauded discount of its obesity drug Zepbound comes with caveats and more... |
| 2024-08-28 12:15 | | Patent thickets in federal government’s crosshairs as election 2024 looms and more... |
| 2024-08-28 00:15 | | Jazz, Hikma must face 'reverse payment' claims over narcolepsy drug and more... |
| 2024-08-27 12:15 | | Eli Lilly rolls out direct patient access to weight loss star Zepbound—at a deep discount and more... |
| 2024-08-27 00:15 | | FDA seeks feedback on predetermined change control plans and more... |
| 2024-08-26 12:15 | | After FDA rejection, Regeneron gains nod in Europe for T-cell engager odronextamab and more... |
| 2024-08-26 00:15 | | Bayer layoffs hit Switzerland with 150 cuts at Basel consumer health hub and more... |
| 2024-08-23 12:15 | | Biopharma VC hit highest quarterly level since 2022, but challenges in exit landscape remain and more... |
| 2024-08-23 00:15 | | Updated COVID shots from Pfizer, Moderna cleared by FDA and more... |
| 2024-08-22 12:15 | | Eli Lilly seeks new angle on high-value target, tapping Oblique for antibody discovery push and more... |
| 2024-08-22 00:15 | | Sustainability is increasingly important in pharma, but several hurdles are slowing the effort: survey and more... |
| 2024-08-21 12:15 | | Biogen sued for alleged PBM kickbacks scheme to boost Tecfidera in wake of generics and more... |
| 2024-08-21 00:15 | | US judge strikes down Biden administration ban on worker 'noncompete' agreements and more... |
| 2024-08-20 12:15 | | Lilly’s tirzepatide cuts diabetes risk, study data show and more... |
| 2024-08-20 00:15 | | Impact of federal negotiation of prescription drug prices and more... |
| 2024-08-19 12:15 | | After SPAC deal fell flat, Visiox acquired by fellow eye-focused biotech and more... |
| 2024-08-19 00:15 | | Forget Mounjaro: Eli Lilly's Next Big Blockbuster Has Arrived and more... |
| 2024-08-16 12:15 | | Genentech to shut down cancer immunology department amid broader R&D rethink and more... |
| 2024-08-16 00:15 | | US court rules for AstraZeneca, erasing Pfizer's $107.5M jury award in patent infringement case and more... |
| 2024-08-15 12:15 | | IRA negotiations slash Medicare prices for Big Pharma blockbusters by up to 79% and more... |
| 2024-08-15 00:15 | | Experts analyze IRA’s effect as the industry awaits negotiated CMS drug prices and more... |
| 2024-08-14 12:15 | | J&J and Roche are the strongest companies in the biopharma industry, says S&P Global and more... |
| 2024-08-14 00:15 | | Abbott’s FreeStyle Libre CGM Meets Medtronic’s Insulin Delivery and more... |
| 2024-08-13 12:15 | | Eli Lilly unwraps $700M nucleic acid R&D center in Boston Seaport, opens doors to biotechs and more... |
| 2024-08-13 00:15 | | Novo Nordisk plots 2024 FDA filing for once-weekly insulin and semaglutide combo and more... |
| 2024-08-12 12:15 | | Pfizer, looking to expand RSV vaccine's reach, touts its benefits in immunocompromised adults and more... |
| 2024-08-12 00:15 | | Biotech giant Amgen announces new office in tech-savvy Hyderabad and more... |
| 2024-08-09 12:15 | | Merck bets $700M on an antibody drug’s potential in immune diseases and more... |
| 2024-08-09 00:15 | | Aldeyra shows FDA-rejected reproxalap improves eye discomfort in new phase 3 study and more... |
| 2024-08-08 12:15 | | Lilly boosts outlook on rising Zepbound revenue and more... |
| 2024-08-08 00:15 | | Bristol Myers cited by FDA for misleading claims on Krazati website and more... |
| 2024-08-07 12:15 | | Novo Nordisk pulls its FDA heart failure submission for Wegovy, will reapply early next year and more... |
| 2024-08-07 00:15 | | Biotech entrepreneur Arie Belldegrun launches new ‘science-first’ credit firm and more... |
| 2024-08-06 12:15 | | Sangamo secures $50M upfront in neurodegenerative pact with Roche's Genentech and more... |
| 2024-08-06 00:15 | | Bristol Myers telegraphs layoffs in New Jersey, trimming 117 jobs in staggered wave of cuts and more... |
| 2024-08-05 12:15 | | 3 Big Pharma companies, 33 phase 3 trials: The race for supremacy in an ADC field and more... |
| 2024-08-05 00:15 | | FDA says all doses of Lilly's weight-loss and diabetes drug are now available and more... |
| 2024-08-02 12:15 | | J&J's DePuy Synthes nets clearance for Velys spine surgery robot and more... |
| 2024-08-02 00:15 | | Driven by Leqembi, Biogen beats Q2 expectations, raises full-year outlook and more... |
| 2024-08-01 12:15 | | Moderna takes axe to '24 sales guidance, sending shares lower and more... |
| 2024-08-01 00:15 | | Biopharma Investment Activity Continued to Rise in Q2: J.P. Morgan and more... |
